A little-known US group headed by an advisor to US President George W. Bush attacked copycat drug makers at the world AIDS forum yesterday, accusing them of exaggerating claims about the costs, safety and effectiveness of their products.
The broadside, aimed at the role of cheap "generic" drugs that are now playing a central role in the AIDS war, was delivered in a full-page advertisement in the Bangkok Post as the International AIDS Conference here began its first day of work.
"Beware of the hype," the ad was headlined. "HIV patients worldwide deserve safe, effective and abundant treatment options -- not false hope and false medicine."
Generic drugs manufacturers copy patented antiretroviral treatments and sell them at prices below those set by the wealthy pharmaceutical giants.
AIDS activists say these firms have helped drive down the cost of an annual regimen of antiretrovirals in developing countries from between US$10,000 and US$12,000 per person two years ago to several hundred US dollars, or even lower, today.
The ad was placed by a group called the AIDS Responsibility Project.
Its Web site says the organization was set up last year with the mission to "educate key policy makers and the general public to the unique needs of traditionally undeserved HIV/AIDS-affected populations."
Its founder and head is identified as Abner Mason, a former policy advisor to the Massachusetts state government. He is a member of the 35-person advisory council on HIV/AIDS to the White House.
"Rather than healthcare by press release, this conference should serve as an occasion to promote the principles of democratic governments; economic freedoms; infrastructure development; safe, approved and effective medicines and property rights," the ad said.
It took specific aim at the Indian generic maker Cipla, claiming the firm had attached "strict conditions" to a promise it had made to the Clinton Foundation that it would provide antiretrovirals for just US$140 a year.
And, it noted, the World Health Organization on May 27 had delisted two Cipla AIDS drugs because they were not "bioequivalent" -- in other words, they did not work in the same way as patented drugs which had been licensed after exhaustive tests for safety and effectiveness.
The pandemic in 23 years has claimed more than 20 million lives and threatens 38 million more who are living with HIV.
European and US pharmaceutical companies have slashed the prices of patented drugs, partly out of goodwill and lobbying pressure but also because of competition from generics, which are principally manufactured in India, Thailand and Brazil.
This has caused the global market for HIV drugs to develop into two tiers: cheap drugs in developing countries and expensive ones in developed nations.
The pharmaceutical giants fought for many years against these rivals, arguing that copied drugs would leak into rich markets and hurt their profits, thus destroying the financial incentive to look for new drugs.
Thailand's health ministry came close to a showdown with US pharmaceutical corporations after it began selling its own locally produced antiretroviral drug in April last year at less than US$1 a day.
A coronavirus-free tropical island nestled in the northern Pacific might seem the perfect place to ride out a pandemic, but residents on Palau said that life right now is far from idyllic. The microstate of 18,000 people is among a dwindling number of places on Earth that still report zero cases of COVID-19 as figures mount daily elsewhere. The disparate group also includes Samoa, Turkmenistan, North Korea and bases on the frozen continent of Antarctica. A dot in the ocean hundreds of kilometers from its nearest neighbors, Palau is surrounded by the vast Pacific Ocean, which has acted as a buffer against the
Dutch scientists have found the coronavirus in a city’s wastewater before COVID-19 cases were reported, demonstrating a novel early warning system for the disease. SARS-CoV-2 — the virus that causes COVID-19 — is often excreted in an infected person’s stool. Although it is unlikely that sewage will become an important route of transmission, the pathogen’s increasing circulation in communities would increase the amount of it flowing into sewer systems, Gertjan Medema and colleagues at the KWR Water Research Institute in Nieuwegein said on Monday. They detected genetic material from the coronavirus at a wastewater treatment plant in Amersfoort on March 5, before
TRUE TOLL? Some Chinese are skeptical about official data, particularly given the overwhelmed medical system and initial attempts to cover up the outbreak The long lines and stacks of urns greeting family members of the dead at funeral homes in Wuhan, China, are spurring questions about the true scale of casualties at the epicenter of the COVID-19 outbreak, renewing pressure on a Chinese government struggling to control its containment narrative. The families of those who succumbed to the coronavirus in the city, where the disease first emerged, were allowed to pick up their cremated ashes at eight funeral homes last week. As they did, photographs circulated on Chinese social media of thousands of urns being ferried in. Outside one funeral home, trucks shipped in about 2,500
KEEN INTEREST: India is trying to procure medical gear from domestic producers and abroad, and China has emerged as a possible supplier as its factories reopen India is to buy ventilators and masks from China to help it deal with COVID-19, a government official said yesterday, even though some countries in Europe had complained about the quality of the equipment. India has recorded 1,251 cases of the coronavirus, with 32 deaths, but health experts said the country of 1.3 billion people could see a major surge in cases that could overwhelm its weak public health system. Indian Prime Minister Narendra Modi’s government said that it was trying to procure medical gear, including masks and body coveralls, both from domestic firms and from countries such as South Korea and